[MYGN] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -64.49%
YoY- 171.43%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 216,800 202,300 200,900 193,500 194,000 190,200 200,500 5.33%
PBT 3,600 800 16,100 16,500 3,700 86,600 18,800 -66.67%
Tax 1,000 1,600 3,000 5,200 -28,400 5,600 6,100 -69.94%
NP 2,600 -700 13,100 11,400 32,100 81,100 12,900 -65.52%
Tax Rate -27.78% -200.00% -18.63% -31.52% 767.57% -6.47% -32.45% -
Total Cost 214,200 203,000 187,800 182,100 161,900 109,100 187,600 9.21%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 1.20 -0.35 6.52 5.89 16.55 42.64 6.43 -67.24%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS 0.04 -0.01 0.19 0.16 0.46 1.18 0.19 -64.51%
EPS Diluted 0.03 -0.01 0.18 0.16 0.45 1.15 0.19 -70.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.